Levetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes (BECTS): An open-label, parallel group trial
- 30 June 2007
- journal article
- research article
- Published by Elsevier in Brain & Development
- Vol. 29 (5) , 281-284
- https://doi.org/10.1016/j.braindev.2006.09.008
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Oxcarbazepine monotherapy in benign childhood epilepsy with centrotemporal spikes: A clinical and cognitive evaluationEpilepsy & Behavior, 2005
- Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy [RETIRED]Neurology, 2004
- Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy [RETIRED]Neurology, 2004
- Levetiracetam for benign epilepsy of childhood with centrotemporal spikes—three casesSeizure, 2003
- Sulthiame as Monotherapy in Children with Benign Childhood Epilepsy with Centrotemporal Spikes: A 6‐Month Randomized, Double‐Blind, Placebo‐Controlled StudyEpilepsia, 2000
- Drug Treatment of Benign Focal Epilepsies of ChildhoodEpilepsia, 2000
- Lamotrigine monotherapy in childrenPediatric Neurology, 2000
- Proposal for Revised Classification of Epilepsies and Epileptic SyndromesEpilepsia, 1989
- Benign Partial Epilepsy—Treatment with SulthiameDevelopmental Medicine and Child Neurology, 1988
- Proposal for Revised Clinical and Electroencephalographic Classification of Epileptic SeizuresEpilepsia, 1981